Monday, April 8, 2013

Share Investor Portfolio: Value @ 8 April 2013

The Share Investor Portfolio  is well up on the previous posting made at the end of 2011.  

The amount of dividends is zero as they are now used for something else so wont be reported here. 


There are also approx $60,000.00 in tax credits earned from the portfolio since it began in late 2002.





My NZX and ASX Portfolio

$194,629.36 (64.82%)$300,281.43

New Zealand Securities

as at 17:30:00, Monday 08 April, 2013 (NZT)
Stock
Quantity
Total cost
Market price
Market value
Change
%

AIA
5,312$6,954.77 DR$2.905$15,431.36$8,476.59121.88%

ASBPB
10,000$6,607.00 DR$0.780$7,800.00$1,193.0018.06%

BGR
3,000$1,598.85 DR$2.500$7,500.00$5,901.15369.09%

CEN
9,200$44,892.00 DR$5.500$50,600.00$5,708.0012.71%

FBU
1,114$7,429.50 DR$8.650$9,636.10$2,206.6029.70%

FPH
20,000$41,816.50 DR$2.540$50,800.00$8,983.5021.48%

FRE
8,631$21,181.05 DR$4.430$38,235.33$17,054.2880.52%

HLG
1,000$1,156.21 DR$5.780$5,780.00$4,623.79399.91%

MFT
5,000$26,676.75 DR$11.250$56,250.00$29,573.25110.86%

MHI
10,000$5,920.06 DR$1.340$13,400.00$7,479.94126.35%

PPL
5,000$11,843.00 DR$1.160$5,800.00$6,043.0051.03%

RYM
5,000$8,553.74 DR$5.100$25,500.00$16,946.26198.12%

SKC
37,100$62,774.00 DR$4.180$155,078.00$92,304.00147.04%

WHS
15,000$52,878.00 DR$3.540$53,100.00$222.000.42%
64.82%
Total costMarket valueChange
$300,281.43 DR$494,910.79$194,629.36



Shareinvestor 2013



Share Price Alert: Fisher & Paykel Healthcare Ltd 5




Fisher & Paykel Healthcare Ltd [FPH.NZX] is a stock that I haven't written much about for about 1 year apart from the stock picks series.

I re-mention it again because of a question I was asked 2 days ago. Is there a stock I would still buy to get a good return and that would provide capital growth.

My answer? Fisher & Paykel.

It is a stock that is still WAY under-priced and I last picked it at its all-time low of $1.85  in August of 2012 and it remains a bargain (keep in mind I have 20000, last bought in January 2012 )which I personally would buy all the way up to 3 dollars even. 

FPH is a well managed company with a good history of increasing profits and revenue based on their manufacture and sale of high end, well sought after medical products that have high margins and a reputation for cutting edge technology which more often than not beats its competition.

The only problem, if there is one, is that much of their business is done in US dollars and due to a weak US buck profits repatriated back to head office in New Zealand have been mostly static over the last 4 years and that will grow marginally in 2013.

The currency affect will always be there so investors just have to deal with this. The company have forward hedging in place this year any weakness expect a currency gain .

Revenue and profits have grown over the years and their new products, especially their sleep apnea range has a good foot in the door in an ever increasing American market with overweight patients knocking on their doctors doors for help. This will clearly increase revenues in the near and long-term future.

The share price has been trading in a tight range over the last 6 weeks between $2.50-$2.70 but has traded as low as $2.35 in February then briefly trading at $2.60 in December then all the way down to $1.85 in the aforementioned all-time low.

You maybe lucky and get it around $2.58 but I am picking a rise come this reporting season, (announced late May 2013), announced by the company itself  and tip a further rise.

I would buy now.


Fisher & Paykel Healthcare

Share Investor's 2013 Stock Picks
Fisher & Paykel Healthcare Ltd 4
Fisher & Paykel Healthcare Ltd 3
Fisher & Paykel Healthcare Ltd 2
Share Investor's 2012 Stock Picks
Global Market Sell-Off Stocks: Fisher & Paykel Healthcare
Resmed takes market share from Fisher & Paykel Healthcare
Resmed kicking Fisher & Paykel Heathcares butt?
Share Price Alert: Fisher & Paykel Healthcare Ltd
I'm Buying: Fisher & Paykel Healthcare Ltd
Share Investor's Total Returns: Fisher & Paykel Healthcare Ltd
Share Investor's 2011 Stock Picks
Stock of the Week: Fisher & Paykel Healthcare Ltd
Fisher & Paykel Healthcare & the US Dollar
Mondrian Investment Partners take stake in Fisher & Paykel Healthcare
Fisher & Paykel Healthcare: 2010 Full Year Profit rests on Foreign exchange movement
Long Term View: Fisher & Paykel Healthcare
Stock of the Week: Fisher & Paykel Healthcare
Analysis - Fisher & Paykel Healthcare: FY Profit to 31/03/09
Schroder Investment Management takes big Fisher & Paykel Healthcare stake
Long VS Short: Fisher & Paykel Healthcare
Big Fisher & Paykel Healthcare trades a curious tale
Why did you buy that stock? [Fisher & Paykel Healthcare]
Drinking and Trading
Share Investor's 2008 stock picks
Fisher & Paykel: A tale of two companies
FPH downgrade masks good performance

Discuss FPH @ Share Investor Forum
Download FPH Company Reports


Share Price Alert Series


Contact Energy Ltd 7
Fletcher Building Ltd 5 
Auckland International Airport Ltd 
Kathmandu Holdings Ltd 2
Mainfreight Ltd 3
Fletcher Building Ltd 4
Fletcher Building Ltd 3
Port of Tauranga Ltd 2
Contact Energy Ltd 5
Ecoya Ltd
Contact Energy Ltd 4
The Warehouse Group Ltd 2
Contact Energy Ltd 3
Contact Energy Ltd 2
Xero Ltd 2
Pumpkin Patch Ltd 4
Pumpkin Patch Ltd 3
Hallenstein Glasson Holdings Ltd
Telecom New Zealand Ltd 4
Telecom New Zealand Ltd 3
Port of Tauranga Ltd
Freightways Ltd 3
Goodman Fielder Ltd 2
Freightways Ltd 2
Telecom New Zealand Ltd 2
Ryman Healthcare Ltd
Charlies Group Ltd
Fletcher Building Ltd 2
Contact Energy Ltd
Steel & Tube Ltd
Telecom New Zealand Ltd
New Zealand Stock Exchange Ltd
Mainfreight Ltd 2
The Warehouse Group Ltd
Pumpkin Patch Ltd 2
Hallenstein Glasson Holdings Ltd 2
Fletcher Building Ltd
Restaurant Brands Ltd
Mainfreight Ltd
Tourism Holdings
Goodman Fielder Ltd
Pumpkin Patch Ltd
Hallenstein Glasson Holdings Ltd
NZ Refining Ltd
Freightways Ltd
Xero Ltd 


Recommended Amazon Reading

The Intelligent Investor: The Definitive Book on Value Investing. A    Book of Practical Counsel (Revised Edition)
The Intelligent Investor: The Definitive Book on Value Investing. A Book of Practical Counsel (Revised Edition) by Benjamin Graham
Buy new: $14.95 / Used from: $6.99
Usually ships in 24 hours



Shareinvestor 2013